These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3361699)

  • 1. An evaluation of fibrinolytic therapy of pulmonary thromboembolism using non-invasive examinations and the relationship of urokinase dosage to clinical outcome and coagulation-fibrinolytic changes.
    Oguma Y; Hasegawa H; Kawakami Y
    Jpn Circ J; 1988 Feb; 52(2):131-8. PubMed ID: 3361699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of dextran sulfate in urokinase therapy and evaluation of the effects by estimation of plasmin inhibitor, fibrinogenolytic degradation products, and fibrinolytic degradation products.
    Hasegawa H; Nagata H; Yamauchi M; Murakoshi T; Oguma Y; Takei H; Seya T; Murao M
    Jpn Heart J; 1982 May; 23(3):339-47. PubMed ID: 6178853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of pulmonary thromboembolism--incidence, diagnosis, classification, pathogenesis, and treatment.
    Hasegawa H
    Jpn Circ J; 1984 Jan; 48(1):100-10. PubMed ID: 6198531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of diagnostic criteria, isotopic perfusion defect and alveolar-arterial oxygen difference in the differential diagnosis of pulmonary thromboembolism and the evaluation of fibrinolytic therapy.
    Oguma Y; Hasegawa H; Kawakami Y
    Hokkaido Igaku Zasshi; 1987 May; 62(3):501-10. PubMed ID: 3610042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increased fibrinolytic activity by sequential treatment with defibrase-plasminogen-urokinase in pulmonary embolism and deep venous thrombosis].
    Brochier M; Griguer P; Raynaud P; Fauchier JP; Charbonnier B
    Arch Mal Coeur Vaiss; 1981 Jul; 74(7):761-9. PubMed ID: 6794497
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in coagulation and fibrinolytic factors observed during heparin-urokinase-pulse combined therapy for nephritis resistant to conventional treatment in children].
    Koitabashi Y; Ikoma M; Shibawaka T; Yamaguchi Y; Mio H; Doi K; Meguro T; Yamada K
    Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1155-61. PubMed ID: 7505345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial.
    Marini C; Di Ricco G; Rossi G; Rindi M; Palla R; Giuntini C
    Respiration; 1988; 54(3):162-73. PubMed ID: 3073463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of combined use of dextran sulfate and urokinase in cases of preeclampsia-behavior of blood coagulation-fibrinolysis and inhibitor systems].
    Mutoh S; Maki M; Takahashi S; Abe T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Sep; 34(9):1519-27. PubMed ID: 6182257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired resolution of massive pulmonary embolism associated with an inhibited fibrinolytic response.
    Deitcher SR; Lucore CL; Eisenberg PR
    Am J Med; 1994 May; 96(5):483-4. PubMed ID: 8192182
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in coagulation and fibrinolytic system after local intra-arterial thrombolysis for acute ischemic stroke.
    Ueda T; Hatakeyama T; Sakaki S; Ohta S; Kumon Y; Uraoka T
    Neurol Med Chir (Tokyo); 1995 Mar; 35(3):136-43. PubMed ID: 7770106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen and moderate doses of urokinase in the treatment of acute pulmonary embolism.
    Griguer P; Charbonnier B; Latour F; Fauchier JP; Brochier M
    Angiology; 1979 Jan; 30(1):1-12. PubMed ID: 426316
    [No Abstract]   [Full Text] [Related]  

  • 15. Pretreatment with heparin in thrombolytic therapy with Urokinase. Heparin-urokinase therapy.
    Bizzi B; Leone G; Accorrà F
    Haemostasis; 1976; 5(3):147-54. PubMed ID: 1002001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].
    Kawakami K; Takahashi A; Yoshimoto T
    No To Shinkei; 1990 Feb; 42(2):193-201. PubMed ID: 2113401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phase II urokinase-streptokinase pulmonary embolism trial: a national cooperative study.
    Sasahra AA; Bell WR; Simon TL; Stengle JM; Sherry S
    Thromb Diath Haemorrh; 1975 Jun; 33(3):464-76. PubMed ID: 1098216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of plasma specific fibrin degradation products during thrombolytic therapy in patients with thrombo-embolism.
    Faivre R; Mirshahi M; Ducellier D; Soria C; Soria J; Mirshahi M; Kieffer Y; Bassand JP; Caen J; Maurat JP
    Thromb Res; 1988 May; 50(4):583-9. PubMed ID: 3413720
    [No Abstract]   [Full Text] [Related]  

  • 19. Urokinase therapy in clinical pulmonary embolism. A new thrombolytic agent.
    Sasahara AA; Cannilla JE; Belko JS; Morse RL; Criss AJ
    N Engl J Med; 1967 Nov; 277(22):1168-73. PubMed ID: 6058604
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombolytic therapy in canine pulmonary embolism. Comparative effects of urokinase and recombinant tissue plasminogen activator.
    Prewitt RM; Hoy C; Kong A; Gu SA; Greenberg D; Cook R; Chan SM; Ducas J
    Am Rev Respir Dis; 1990 Feb; 141(2):290-5. PubMed ID: 2105682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.